This isn't failureit reflects how your body's hunger systems recalibrate once GLP-1 medication stops
GLP-1 access in India is shaped by three layers: patent timing, regulatory approvals, and the ability of Indian companies to manufacture high-quality peptide and biologic-like products at scale.[5] 2.1 How Indian Patent Law Shapes GLP-1 Access Under Indian patent law, drug molecules get 20-year protection from the date of filing, but only for truly novel inventions, not for minor tweaks
prescription, or markets "research chemical" versions of these medications
Combining Wegovy with other weight loss medications has not been studied in clinical trials, raising concerns about unpredictable cardiovascular effects, worsened gastrointestinal side effects, and potential psychiatric or neurological risks
We dont believe in quick fixes or one-size-fits-all plans